Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesRemarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseasesCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisThe Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activityInduction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behaviorEffects of various phytochemicals on indoleamine 2,3-dioxygenase 1 activity: galanal is a novel, competitive inhibitor of the enzymeLPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia.Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice culturesL-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.Kynurenine and depressive symptoms in a poststroke population.Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains.Kynurenine pathway metabolites in humans: disease and healthy States.The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner.Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts.Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.Microbiome alterations in HIV infection a review.Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug developmentActivation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines.Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulationIndoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapyThe association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*.The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathwayDipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration.Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDOImmune system dysregulation in adolescent major depressive disorder.A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression.Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.
P2860
Q21129356-A6E1FF92-5C29-4321-8AD9-1F730FC9C046Q21285076-6FC63745-ADF9-4A72-9479-565640FD084EQ26740330-39783D00-84B7-4872-BA64-0BAA65FD4CAAQ26785900-C313DD7C-778B-4770-A4AE-E98FC3D33CE2Q27863347-E01C6B06-8D5B-4879-B616-0DC565D074F4Q28508390-33A47DEF-FA06-48A5-BCD3-79C640923C47Q28539745-37D6178A-8147-499C-9BD7-1582C331F4DDQ33635999-2CF5A61E-7E50-4C4E-9799-4E16682CCC8AQ33743826-9D4C559B-6749-4300-9A7A-3F897C9CF62DQ33889154-90B3E301-6B86-45E0-B400-96801563A7F2Q34064890-B7304586-DAC8-4831-B862-49307280B7E9Q34116625-8B636B1B-A94C-4D0E-8A10-7F61E446B8B4Q34274565-654D5487-5136-42BF-B297-06604A90849DQ34359001-30D74D78-DF51-4421-8CD1-DEC633BD0F60Q34633683-1F2E81E8-15AF-4B99-97BB-924FBCA5ED58Q35029070-CBD159F5-82B3-4F48-8DAD-93394EA3EC22Q35139241-2798A3F0-9272-4A3D-91C9-DA6472A805B7Q35183177-EA430552-D20E-4522-BEA3-77D392CECE82Q35216385-BBB87D2F-35E8-4696-AD49-5CFDC5C1F8FEQ35317241-FAF5926E-480D-42EC-BD51-4D10BB3EB6C5Q35674541-E860A40A-A02C-4563-969A-DC628BAC7894Q35847753-6AB630BD-BEAA-4210-98D2-5096E2B620B5Q35946623-9D4459E4-5F33-4176-B1B0-351BCEB719ADQ36154064-C2147E42-E4FA-42DA-9DC3-51879A812B19Q36202875-99799ADA-D7E8-4657-89D7-D27EC176134CQ36207412-546524F7-4035-4173-A5D2-9EBB048BAC3CQ36213003-9624A357-A1E6-474E-9088-5A56E4D1B346Q36559288-62379E95-987C-4EF7-A185-E506F6659E5FQ36642844-F3125F44-7C30-4789-8144-EBCC8689BE1FQ36646476-705BA792-33D7-4ADA-A2B4-0E9137A348F0Q36763697-E8D4694F-966B-4E0C-B428-749349CED24FQ36892321-19726065-3439-497A-9CD2-E4794A6FB8E7Q36911412-B7C26FD4-EEF4-4D2E-9A5A-1389EA66F55EQ36945216-250D8BDD-8ECA-4C64-8127-C5050DDC4224Q37031204-CE90491B-E447-4C2B-9B0E-64003F16EBBBQ37222162-7A1FA73B-1253-422F-8707-3B58E5221F16Q37406191-E43E2309-AA4E-4EA4-9AEC-10B590E2570CQ37422841-4A2B252A-6C3B-4055-B8FF-2E95A72BDB06Q37602166-D807D357-2089-472D-A644-553E1A2E86CCQ37681536-40B7A71D-5E6E-40A7-A7FC-5747AF794280
P2860
Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Lipopolysaccharide induction o ...... N-gamma-independent mechanism.
@en
Lipopolysaccharide induction o ...... N-gamma-independent mechanism.
@nl
type
label
Lipopolysaccharide induction o ...... N-gamma-independent mechanism.
@en
Lipopolysaccharide induction o ...... N-gamma-independent mechanism.
@nl
prefLabel
Lipopolysaccharide induction o ...... N-gamma-independent mechanism.
@en
Lipopolysaccharide induction o ...... N-gamma-independent mechanism.
@nl
P2093
P2860
P1476
Lipopolysaccharide induction o ...... N-gamma-independent mechanism.
@en
P2093
Fujigaki S
Seishima M
Sekikawa K
Takikawa O
P2860
P304
P356
10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S
P407
P577
2001-08-01T00:00:00Z